Back to RENAISSANCE TECHNOLOGIES LLC RENAISSANCE TECHNOLOGIES LLC

UTHRUTHR
27 quarters

Position history for RENAISSANCE TECHNOLOGIES LLCRENAISSANCE TECHNOLOGIES LLC's holdings in UNITED THERAPEUTICS CORP

RENAISSANCE TECHNOLOGIES LLC holds 1.7M shares of UTHR (UNITED THERAPEUTICS CORP), worth $925.8M as of 2026-Q2. The position was decreased (-4.4% shares). UTHR represents 1.3% of RENAISSANCE TECHNOLOGIES LLC's portfolio.

Current Value

$925.8M

Current Shares

1.7M

Total Value Change

+$613.7M

Total Shares Change

-1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.7M
-4.4%
$925.8M1.3%$541.83
0
2026-Q1
Decreased
1.8M
-6.4%
$1.1B1.7%$498.65
0
2025-Q4
Decreased
1.9M
-12.2%
$930.3M1.4%$496.19
0
2025-Q3
Increased
2.2M
+2.6%
$911.1M1.2%$424.31
51
2025-Q2
Increased
2.1M
+0.6%
$608.9M0.8%$284.27
45
2025-Q1
Increased
2.1M
+0.8%
$649.5M1.0%$306.97
45
2024-Q4
Decreased
2.1M
-3.1%
$737.2M1.1%$357.64
0
2024-Q3
Decreased
2.2M
-0.9%
$772.4M1.2%$358.53
0
2024-Q2
Increased
2.2M
+1.1%
$692.7M1.2%$318.55
50
2024-Q1
Decreased
2.2M
-0.8%
$494.3M0.8%$229.72
0
2023-Q4
Decreased
2.2M
-3.6%
$477.2M0.7%$219.89
0
2023-Q3
Increased
2.3M
+2.9%
$508.3M0.9%$225.87
45
2023-Q2
Decreased
2.2M
-1.8%
$482.8M0.7%$219.79
0
2023-Q1
Decreased
2.2M
-5.0%
$498.9M0.7%$219.00
0
2022-Q4
Decreased
2.3M
-8.1%
$652M0.9%$278.09
0
2022-Q3
Decreased
2.6M
-8.7%
$534M0.8%$207.94
0
2022-Q2
Increased
2.8M
+1.0%
$658.3M0.8%$238.29
45
2022-Q1
Decreased
2.8M
-5.2%
$496.1M0.6%$175.63
0
2021-Q4
Decreased
2.9M
-3.7%
$630.3M0.8%$215.18
0
2021-Q3
Decreased
3M
-2.6%
$559M0.7%$185.50
0
2021-Q2
Decreased
3.1M
-3.0%
$558M0.7%$177.00
0
2021-Q1
Decreased
3.2M
-11.1%
$536.5M0.7%$165.47
0
2020-Q4
Decreased
3.6M
-2.7%
$547.6M0.6%$148.68
0
2020-Q3
Decreased
3.7M
-0.5%
$374.6M0.4%$101.04
0
2020-Q2
Increased
3.7M
+3.8%
$450.9M0.4%$119.96
39
2020-Q1
Increased
3.6M
+1.3%
$340.4M0.3%$97.07
37
2019-Q4
New
3.5M
-
$312.2M0.2%$86.91
51

Other major holders of UTHR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used